Vitamin D deficiency is associated with increased human sinonasal fibroblast proliferation in chronic rhinosinusitis with nasal polyps
Background Vitamin D3 (VD3) is a steroid hormone with known antiproliferative properties. Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) have been shown to be VD3‐deficient. Moreover, VD3 deficiency is associated with worse disease in patients with CRSwNP. One cell type thought to p...
Saved in:
Published in | International forum of allergy & rhinology Vol. 6; no. 6; pp. 605 - 610 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Blackwell Publishing Ltd
01.06.2016
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background
Vitamin D3 (VD3) is a steroid hormone with known antiproliferative properties. Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) have been shown to be VD3‐deficient. Moreover, VD3 deficiency is associated with worse disease in patients with CRSwNP. One cell type thought to play a role in chronic rhinosinusitis (CRS) is the human sinonasal fibroblast (HSNF). The aim of this study was to investigate VD3 deficiency and HSNF proliferation in CRSwNP.
Methods
Blood and sinus tissue explants were collected at the time of surgery from patients with CRSwNP (n = 15). Control subjects (n = 12) were undergoing surgery for cerebrospinal fluid leak repair or to remove non–hormone‐secreting pituitary tumors. Ex vivo HSNF proliferation was analyzed with flow cytometry using expression of fibroblast‐specific protein (FSP) and the proliferation marker Ki67. Plasma levels of 25‐hydroxyvitamin D3 (25VD3) were measured by enzyme‐linked immunosorbent assay. In vitro analysis of HSNF proliferation after treatment with calcitriol (1,25VD3) was performed using carboxyfluorescein succinimidyl ester (CFSE) and analyzed with flow cytometry.
Results
In CRSwNP patients there was an inverse correlation between 25VD3 and proliferating HSNFs (p = 0.0135). This correlation was not seen for control patients (p = 0.3869). In vitro analysis showed that HSNFs from patients with CRSwNP had a higher proliferation index at baseline than HSNFs from control patients (p < 0.01). When treated with 1,25VD3, there was a significant decrease in HSNF proliferation index in patients with CRSwNP (p < 0.01), but not control patients.
Conclusion
VD3 deficiency is associated with increased HSNF proliferation in CRSwNP. Further investigation into how HSNFs and VD3 impact CRSwNP pathophysiology is warranted. |
---|---|
Bibliography: | ark:/67375/WNG-P0TP58LF-7 istex:01B678E8335B9D331936CDAEC0AF7FA474A7FEEA ArticleID:ALR21704 Potential conflict of interest: Z.M.S., consultant for Olympus; R.J.S., consultant for Olympus and Arrinex, grant support from Optinose, Intersect ENT, and Entellus. This material is the result of work supported with resources and the use of facilities at the Ralph H. Johnson VA Medical Center, Charleston, SC. The contents do not represent the views of the Department of Veterans Affairs or the United States Government. Funding sources for the study: American Academy of Otolaryngology–Head and Neck Surgery (to W.W.C.); Flight Attendant Medical Research Institute (092401 to J.K.M.; 113039 to R.J.S.); Department of Veterans Affairs, Veterans Health Administration, Clinical Sciences Research and Development Merit Award (CSRD 1I01CX000377‐01A2 to R.J.S.). ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 2042-6976 2042-6984 |
DOI: | 10.1002/alr.21704 |